World Drug Safety Congress
Share
Event details
The World Drug Safety Congress Europe 2025 will convene over 1,800 key thought leaders on October 7–8, 2025, at the RAI Amsterdam Convention Centre. This premier event focuses on the latest advancements in pharmacovigilance, including the integration of big data and AI, benefit-risk management strategies, and patient-centric approaches. Attendees will explore how innovative technologies are shaping the future of drug safety and impacting patient outcomes.
QbD Group, your life sciences partner across the entire product lifecycle
Join QbD Group at booth 34 and discover how we can help you strengthen drug safety, ensure compliance, and accelerate success across the entire product lifecycle.
- Discover our PV solutions: from signal detection to post-market compliance, explore how our end-to-end pharmacovigilance services support you across every stage of the product lifecycle.
- Test your knowledge with our PV quiz: participate in our interactive challenge and see how your expertise measures up while learning something new.
- Connect with our PV experts: get tailored advice from specialists on regulatory expectations, risk management, and global PV compliance strategies.
- Access exclusive PV insights: stay ahead with expert perspectives on industry trends, evolving guidelines, and the future of pharmacovigilance.
Connect with our team of experts
We invite you to meet our team at the World Drug Safety Congress 2025. Whether you’re seeking support in pharmacovigilance, regulatory affairs, or drug safety strategies, QbD Group is here to guide you through the latest developments in the field.
Get in touch with us at WDSC 2025 or contact us today to explore how we can support your journey.
.png?width=720&height=720&name=Marin%20Vrhovac%20(NO%20BG).png)
Marin Vrhovac
Marin Vrhovac is a life sciences business development professional with expertise in regulatory affairs, pharmacovigilance, and quality systems.
He supports pharma and biotech companies across the product lifecycle, building trusted global partnerships and aligning client needs with regulatory and technical solutions.
.png?width=676&height=676&name=Susan%20Veissi%20(NO%20BG).png)
Susan Veissi
Susan Veissi, PhD, is an Account Manager at QbD Group with a background in nephrology and molecular biology.
She drives business growth across biotech, pharma, and medtech, combining her scientific expertise with a passion for advancing patient care.
Fluent in multiple languages, Susan excels at building client relationships and delivering innovative solutions in healthcare.
.png?width=720&height=720&name=Izabela%20Procino%20(NO%20BG).png)
Izabela Procino
Izabela Procino is Senior Business Development Manager Pharma at QbD Group, where she supports pharmaceutical companies in navigating complex regulatory environments and bringing safe, effective products to market.
She combines commercial expertise with a strong understanding of the pharma value chain to build lasting client partnerships.
Get in touch
Have a question or need more information? We’re here to help! Fill out the form and our team will get back to you as soon as possible.
Let’s start the conversation!
.png?width=1600&height=900&name=Hero%20image%20(5).png)
Don't miss the latest updates in life sciences
